Drugs / Hib
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00488683 Background | Jul 2007 → May 2009 | meningococcal infection | Novartis Vaccines | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Hib | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00488683 ↗ |
| Modality | Vaccine | “routine vaccines - 3 doses of DTaP-Hib-IPV (at 2, 3, and 4 months), 3 doses of PCV (at 2, 4, and 13 months), and 1 dose each of MMR and Hib (booster) at 13 months.” NCT00488683 ↗ |
| Route | Intramuscular | “IM injection of one dose 0.5 mL of Hib supplied in pre-filled syringe was administered” NCT00488683 ↗ |